Pembrolizumab,Cisplatin,Gemcitabine,Pemetrexed
merck
['keytruda', 'lung', 'ts,perio,i', '$mrk']
keytruda cuts risk of recurrence, progression or death by 42% in perioperative lung cancer study $mrk #asco23 
The latest global #pharma news, insights, analysis, and views providing you with an information edge.  FirstWord Pharma. Where people who know first, go first.